Advanced Accelerator Applications Gets Positive EMA Opinion on Application for SomaKit TOC
EMA has issued a positive opinion on the marketing authorization application for SomaKit TOC 40µg kit.
This device kit was developed for preparation of gallium-edotreotide solution for injection for Positron Emission Tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or expected gastroenteropancreatic neuroendocrine tumors (GEP-NET) to identify primary tumors and their metastases.
The European Commission’s official marketing authorization is expected soon. — Cynthia Jessup